Markets:

Overview

News

Currencies

International

Treasuries

Stryker Corp (NY:SYK)

366.47 -1.28 (-0.35%)

Streaming Delayed Price Updated: 3:22 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever ↗

December 15, 2024

These companies have ingrained competitive advantages in an evergreen industry backed by decades of dividend growth.

Via The Motley Fool

PepsiCo To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Thursday ↗

December 12, 2024

Via Benzinga

Stryker declares an $0.84 per share quarterly dividend

December 10, 2024

From Stryker Corporation

Via GlobeNewswire

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Stryker ↗

December 02, 2024

Via Benzinga

Analyst Expectations For Stryker's Future ↗

October 30, 2024

Via Benzinga

Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today ↗

October 24, 2024

Via Benzinga

This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

December 02, 2024

Via Benzinga

Based on good technical signals, STRYKER CORP is potentially setting up for a breakout. ↗

November 08, 2024

STRYKER CORP (NYSE:SYK) Reveals Intriguing Technical Aspects. Here's What You Need to Know.

Via Chartmill

Jim Cramer Likes Cava Group, Calls This Utilities Stock 'Terrific' ↗

November 01, 2024

On Oct. 29, Citigroup analyst Jon Tower maintained Cava Group with a Neutral and raised the price target from $115 to $140.

Via Benzinga

Stryker reports third quarter 2024 operating results

October 29, 2024

From Stryker Corporation

Via GlobeNewswire

Tech Stocks Rise Ahead Of Key Earnings, Gold Smashes Records, Bitcoin Nears All-Time Highs: What's Driving Markets Tuesday? ↗

October 29, 2024

Wall Street took a breather on Tuesday, with most major indices treading water, while tech stocks saw gains as investors braced for earnings reports from mega-cap companies.

Via Benzinga

Looking Into Stryker's Recent Short Interest ↗

October 24, 2024

Via Benzinga

The Latest Analyst Ratings For Stryker ↗

October 14, 2024

Via Benzinga

Stryker’s Acquisition Spree: Double-Digit Growth on the Horizon

October 10, 2024

Stryker has acquired several firms over the last few months, including one related to AI. Do these purchases make the stock a buy?

Via MarketBeat

Topics Artificial Intelligence

Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today ↗

October 08, 2024

Via Benzinga

Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today ↗

October 01, 2024

Via Benzinga

How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

October 01, 2024

How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

Via News Direct

Here's How Much You Would Have Made Owning Stryker Stock In The Last 15 Years ↗

September 10, 2024

Via Benzinga

Deep Dive Into Stryker Stock: Analyst Perspectives (11 Ratings) ↗

August 28, 2024

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

September 20, 2024

The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers and what could be ahead.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 18, 2024

Via Benzinga

Stryker completes acquisition of care.ai

September 17, 2024

From Stryker Corporation

Via GlobeNewswire

Boston Scientific: Why This MedTech Giant Isn’t Slowing Down

September 17, 2024

Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.

Via MarketBeat

Stryker Unveils New Foot & Ankle Solutions With Truss Implants: Details ↗

September 11, 2024

Stryker Corporation announced new Foot & Ankle products from 4WEB Medical, with analysts maintaining positive ratings.

Via Benzinga

Stryker Expands Foot & Ankle Portfolio With Specialized Offerings Designed to Enhance Surgical Precision and Outcomes

September 11, 2024

From Stryker

Via Business Wire

Medtronic Stock: Growth On Rise of the Cardiovascular Machines

September 09, 2024

Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases

Via MarketBeat

This Is Great News for Medtronic, but Is It Time to Buy the Stock? ↗

August 26, 2024

This MedTech leader is back on track with profitable growth.

Via The Motley Fool

Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally

August 23, 2024

Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance.

Via MarketBeat

Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions

August 22, 2024

From Stryker Corporation

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.